General Information
Nilotinib, the active ingredient of nilotinib , belongs to the class of molecules termed antineoplastic agents, which inhibit the maturation, growth or spread of tumor cells. It is used for the treatment of chronic myeloid leukemia (CML) in patients exhibiting an abnormal chromosome called the Philadelphia chromosome.
About the API
-
Japan DMF
-
Korea DMF
-
US DMF
The information detailed herein, including that with regard to active pharmaceutical ingredients , their use in treatments and possible mechanism(s) of action, was all obtained from public sources.
For more information on our services and products – including product suitability, intended uses and current availability – please contact Teva api Customer Service. CAS Registry Number is a Registered Trademark of the American Chemical Society. This webpage and any reference to the above product is to be read within the meaning and terms of the Legal Notes.